Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled clinical trial of Immodin immunological efficacy in healthy adult volunteers
2012-001709-26Phase 3Completed
- Sponsor
- Sevapharma
- Start
- May 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in immune system process comparing Immodin arm with Placebo arm (2 arms). Primary endpoint: Immunological effectiveness (parameters of cellular immunity). Started May 2012; status: completed.
02
Drugs
Transferon
03
Conditions
immune system process
Beyond the preview
Go deeper on 2012-001709-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001709-26.